8 studies on PNC-27 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Bottom line: TitrateLab currently tracks 67 published third-party lab tests of PNC-27 across 36 identified manufacturers. Among reports with a positive numeric purity result, the average is 99.3%. Within this published corpus, 0 positive purity results were below 90%, and 4 reports showed measured quantity more than 10% below the label claim. These are batch-level observations, not guarantees of product identity, safety, or vendor quality.
As of 2026-09-03, vendor-blind retail asking-price averages for the US delivery market, calculated from the same in-stock exact-strength cells as the Peptide Price Index. Shipping is excluded.
| Strength | Average / vial | Observed range / vial | Average / mg | Coverage |
|---|---|---|---|---|
| 5 mg | $12.50 | $12.50–$12.50 | $2.50 | 1 source · 1 offer |
| 30 mg | $35.50 | $35.50–$35.50 | $1.18 | 1 source · 1 offer |
Asking prices are not manufacturing cost and do not establish product equivalence, quality, safety, or legality. The refresh date is the catalog build date; individual source observation dates are not available in this snapshot. View full price methodology →
Independent certificate-of-analysis evidence from third-party labs — the data behind the studies. Updated as new COAs are verified. Read the full grey-market analysis →
Within that total, 14 batches have unresolved manufacturer identity. They remain in corpus-level lab evidence and are excluded from named-manufacturer rankings.
Eligible vendors have at least 2 deduplicated tests and 2 classifiable identity observations. Rank uses the 95% lower confidence bound on clean identity results; mean positive purity and test count break ties. Missing measurements are not passes. Exact-zero/not-detected and explicit wrong-compound markers count once per adverse certificate. This describes tested batches, not every product or shipment, and is not an endorsement.
| Rank | Manufacturer | Tests | Avg positive purity | Identity adverse results | |
|---|---|---|---|---|---|
| #1 | 6 | 99.27% | 0 of 6 (0.0%) 0 0% / not detected · 0 wrong compound | Reveal with Pro → | |
| #2 | 3 | 99.73% | 0 of 3 (0.0%) 0 0% / not detected · 0 wrong compound | Reveal with Pro → | |
| #3 | 3 | 99.62% | 0 of 2 (0.0%) 0 0% / not detected · 0 wrong compound · 1 unclassified | Reveal with Pro → |
Manufacturer identities are included with Pro. Batch counts and lab measurements remain visible.
Recent certificates: #87320 (99.2%) · #94628 (99.03%) · #85155 (99.13%) · #85130 (99.17%) · #79990 (99.06%) · #68903 (99.62%)
This innovative high-yield recombinant expression system represents a significant advancement in peptide biotechnology, potentially making therapeutic peptides more accessible and affordable. By improving production e…
This research is profoundly significant because it provides compelling ex vivo evidence for PNC-27's potent anti-cancer activity in a highly relevant model using actual human patient samples. This approach offers a mo…
This study provides compelling in-vitro evidence that **PNC-27** can selectively target and induce necrosis in **leukemia** cells by binding to membrane `HDM-2`. **This mechanism offers a potential pathway for develop…
This research highlights PNC-27 as a promising dual-mechanism anti-cancer agent that targets both an intracellular protein (HDM-2) and the cell membrane. Its selective toxicity towards cancer cells, while sparing norm…
This study underscores the urgent need for targeted interventions to support mothers who have experienced child loss in Nigeria, ensuring they receive adequate maternal healthcare for subsequent pregnancies. Understan…
This study provides crucial insights into the molecular mechanisms governing the stability and efficacy of p53-derived anticancer peptides, highlighting the critical role of the ETFS amino acid sequence. The findings …
This conceptual framework for poptosis represents a potentially groundbreaking shift in cancer treatment strategy. By proposing a mechanism for highly selective cancer cell destruction, it addresses a major limitation…
The potential significance of PNC-27 remains entirely theoretical without empirical data on its biological interactions. Its intricate peptide structure suggests it could potentially interact with various biological t…
Free, no account — handy when you're working with PNC-27.
Pro members save studies and unlock the full evidence breakdown and vendor lab data.
Buyer protection: Wrong or defective product? Report it within 7 days. We broker a refund or reship with the vendor.
$12 monthly or $33 lifetime
Create free account